Ketamine and Depression During Perimenopause and Menopause
Depression risk rises sharply in perimenopause and is often dismissed. Here is what helps, where ketamine fits, and what the research actually shows for this transition.

Ketamine Uplift Education
Patient Care Team
Conditions
Short answer: The menopause transition roughly doubles to quadruples the risk of depression, driven in part by real hormonal shifts, and it is one of the most dismissed forms of depression in medicine. First-line care, therapy, antidepressants, and for many women hormone therapy, genuinely helps and comes first. Where ketamine fits: research shows it works for treatment-resistant depression equally well regardless of menopausal status, making it a legitimate option when the standard toolkit has not been enough. Here is the honest picture.
The depression nobody takes seriously enough
Perimenopause, the years of hormonal transition before periods end, is a documented window of sharply elevated depression risk, including first-ever episodes in women with no history, and relapses in women who thought that chapter closed. The biology is real: research points to estradiol withdrawal as a genuine physiologic trigger for depressive symptoms in susceptible women, which means this is chemistry, not character, and certainly not "just getting older." Yet women in this window routinely hear their symptoms waved off as stress or aging, a dismissal that costs years. If your mood changed when your cycle did, you are not imagining the connection.
What first-line care looks like here
Honest order of operations, built with your OB-GYN and a psychiatrist: therapy remains foundational; standard antidepressants help many women in this window; and hormone therapy deserves a real conversation, since treating the hormonal driver sometimes lifts the mood symptoms it was driving, alongside the sleep disruption and hot flashes that wreck nights and compound everything. This combination resolves perimenopausal depression for many women, and nobody should skip it for something newer.
Where ketamine fits, with the evidence stated straight
Ketamine enters this story exactly where it enters every depression story: when adequate trials of standard care have not delivered, the territory of treatment-resistant depression. The specific reassurance for this audience comes from clinical data: in a Canadian study of IV ketamine for treatment-resistant depression, postmenopausal women responded at rates similar to premenopausal women, with menopausal status making no significant difference, preliminary but meaningful evidence that this treatment does not stop working when hormones shift. What ketamine is not: a hormone, a menopause treatment, or a remedy for hot flashes. It treats the depression, through the glutamate mechanism that works independently of estrogen, which is precisely why it remains available when hormonally-linked depression resists everything else.
The both-and approach
The practical path for many women is combination, not either-or: hormone therapy addressing the driver where appropriate, psychiatric care holding the frame, and ketamine providing the rapid lift and neuroplasticity window when the depression itself has dug in. Treatment here also deserves coordination, your OB-GYN, your psychiatrist, and your ketamine physician comparing notes, which is how we work at Ketamine Uplift. The usual screening applies, with the note that this life stage is exactly when cardiovascular screening earns its keep.
You are allowed to take this seriously
If the last year or two of your life has featured a mood you do not recognize, rage or tears arriving uninvited, sleep in pieces, and a doctor who shrugged, hear this clearly: perimenopausal depression is real, common, biological, and treatable, and pursuing real care for it is not dramatic. It is appropriate.
If you are having thoughts of harming yourself, please reach out now. Call or text 988 any time.
This article is for educational purposes only and is not medical advice. Coordinate care with your OB-GYN and mental health providers.
The bottom line
The menopause transition multiplies depression risk through real biology, first-line care including hormone therapy deserves a genuine trial, and when depression resists it, ketamine works in this population just as it does in others, with study data showing menopausal status does not blunt the response. If this transition has been heavier than anyone warned you, call us at (310) 280-4440.
Frequently asked questions
Can ketamine help depression during menopause? When depression has resisted standard care, yes: study data shows IV ketamine works similarly in premenopausal and postmenopausal women with treatment-resistant depression. It treats the depression itself, not menopause symptoms.
Why does depression risk rise in perimenopause? Hormonal shifts, particularly estradiol withdrawal, act as a genuine physiologic trigger in susceptible women, often compounded by disrupted sleep. It is biology, not weakness.
Should I try hormone therapy before ketamine? Hormone therapy, antidepressants, and therapy are the first conversation, with your OB-GYN and a psychiatrist. Ketamine is considered when adequate standard care has not delivered.
Does ketamine affect hormones or hot flashes? No. Ketamine is not a hormone and does not treat vasomotor symptoms. It works on the brain's glutamate system, which is why it helps depression independently of hormonal status.

Ketamine Uplift Education
Patient Care Team
You might also like
Cost & Getting Started
Hope & Healing
What to Expect







